| 000 | 02780nam a2200325 4500 | ||
|---|---|---|---|
| 001 | ESSALUD | ||
| 005 | 20260819164758.0 | ||
| 007 | ta | ||
| 008 | t pe ||||| |||| 00| 0 spa d | ||
| 040 | _aBMG | ||
| 041 | _aeng | ||
| 100 |
_aFrat, Jean-Pierre _eAutor _954172 |
||
| 245 | _aHigh-flow or standard oxygen in acute hypoxemic respiratory failure | ||
| 300 | _apáginas: 2095-2106 | ||
| 520 | _aBackground: Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure. Methods: In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemic respiratory failure to receive high-flow-oxygen or standard-oxygen therapy. All the patients had a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 or less, a respiratory rate of more than 25 breaths per minute, and pulmonary infiltrate on chest imaging. The primary outcome was death by day 28. Results: A total of 1116 patients underwent randomization. Of these patients, 1110 (556 in the high-flow-oxygen group and 554 in the standard-oxygen group) were included in the analysis. Mortality at day 28 was 14.6% (in 81 of 556 patients) in the high-flow-oxygen group and 14.6% (in 81 of 554 patients) in the standard-oxygen group (difference, −0.05 percentage points; 95% confidence interval [CI], −4.21 to 4.10; P=0.98). The incidence of intubation by day 28 was 42.4% (in 236 of 556 patients) in the high-flow-oxygen group and 48.4% (in 268 of 554 patients) in the standard-oxygen group (difference, −5.93 percentage points; 95% CI, −11.78 to −0.08). Serious adverse events (cardiac arrest or pneumothorax) occurred during spontaneous breathing in 13 patients (2.3%) in the high-flow-oxygen group and in 6 patients (1.1%) in the standard-oxygen group. Conclusions: Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28. | ||
| 650 |
_aCUIDADOS INTENSIVOS _95208 |
||
| 650 |
_aMEDICINA DE URGENCIAS _953820 |
||
| 650 |
_aMEDICINA CLINICA HOSPITALARIA _953754 |
||
| 650 |
_aVENTILACION MECANICA _937360 |
||
| 650 |
_aNEUMOLOGÍA _925628 |
||
| 700 |
_aQuenot, Jean-Pierre _954173 |
||
| 700 |
_aGuitton, Christophe _954174 |
||
| 700 |
_aCoudroy, Rémi _954175 |
||
| 700 |
_aGacouin, Arnaud _954176 |
||
| 700 |
_aBadie, Julio _954177 |
||
| 700 |
_aDemoule, Alexandre _954178 |
||
| 700 |
_aContou, Damien _954179 |
||
| 773 | 0 |
_022717 _922648 _dMassachusetts NEJM Group _oNEJM011 _tThe New England Journal of Medicine _wESSALUD _x0028-4793 |
|
| 942 |
_cARTICULOS _e2026-08-19 _zsqb |
||
| 999 |
_c22834 _d22834 |
||